SC Tysabri (natalizumab) Mode of action and the risk of PML
This page is intended for physicians in the Nordic and Baltic countries and for nurses in Sweden, Denmark, Norway, Latvia and Lithuania.
Biogen Sweden AB | Vasagatan 7 | 111 20 Stockholm, Sweden
Biogen (Denmark) A/S | Strandvejen 125 | 2900 Hellerup, Denmark
Biogen Norway AS | Vitaminveien 1 A, 0485 Oslo postboks 4305 Nydalen, 0402
Oslo, Norway
Biogen Finland Oy | Bertel Jungin aukio 5c | 02600 Espoo, Finland
Biogen Estonia OÜ | Hobujaama tn 4 | 10151 Tallinn, Estonia
Biogen Latvia SIA | Audēju 15-4 | Rīga, Latvia
Biogen Lithuania, UAB | Gedimino pr. 20 | LT-01103 Vilnius, Lithuania
Biogen-242070 | 7 Dec 2024